Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab...
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors
About this item
Full title
Author / Creator
Khushalani, Nikhil I , Ott, Patrick A , Ferris, Robert L , Cascone, Tina , Schadendorf, Dirk , Le, Dung T , Sharma, Manish R , Barlesi, Fabrice , Sharfman, William , Luke, Jason J , Melero, Ignacio , Lathers, Deanne , Neely, Jaclyn , Suryawanshi, Satyendra , Sanyal, Abanti , Holloway, James L , Suryawanshi, Rasika , Ely, Scott and Segal, Neil H
Publisher
England: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundResistance to immune checkpoint inhibitors and targeted treatments for cancer is common; thus, novel immunotherapy agents are needed. Urelumab is a monoclonal antibody agonist that binds to CD137 receptors expressed on T cells. Here, we report two studies that evaluated urelumab in combination with cetuximab or nivolumab in patients with...
Alternative Titles
Full title
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors
Authors, Artists and Contributors
Author / Creator
Ott, Patrick A
Ferris, Robert L
Cascone, Tina
Schadendorf, Dirk
Le, Dung T
Sharma, Manish R
Barlesi, Fabrice
Sharfman, William
Luke, Jason J
Melero, Ignacio
Lathers, Deanne
Neely, Jaclyn
Suryawanshi, Satyendra
Sanyal, Abanti
Holloway, James L
Suryawanshi, Rasika
Ely, Scott
Segal, Neil H
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6310bf50e26a495fafc831096d8929f8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6310bf50e26a495fafc831096d8929f8
Other Identifiers
ISSN
2051-1426
E-ISSN
2051-1426
DOI
10.1136/jitc-2023-007364